1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. THERAVANCE BIOPHARMA INC
Theravance Biopharma Inc XNAS: TBPH
18.50 3.42 (22.68%)
1.5M

XNAS 11 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for Theravance Biopharma Inc is on 12 Nov 2025 for the purpose of Theravance Biopharma Inc Third Quarter Earnings Results for 2025 See details

Theravance Biopharma Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents